FDA Inspection 1049910 — Geritrex Corporation
The FDA completed an inspection of Geritrex Corporation on Apr 18, 2018 in Middletown, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Middletown, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)